These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31958512)

  • 1. Beta-blocker therapy and risk of vascular dementia: A population-based prospective study.
    Holm H; Ricci F; Di Martino G; Bachus E; Nilsson ED; Ballerini P; Melander O; Hansson O; Nägga K; Magnusson M; Fedorowski A
    Vascul Pharmacol; 2020; 125-126():106649. PubMed ID: 31958512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Terminal Prosomatostatin and Risk of Vascular Dementia.
    Holm H; Nägga K; Nilsson ED; Ricci F; Cinosi E; Melander O; Hansson O; Bachus E; Magnusson M; Fedorowski A
    Cerebrovasc Dis; 2017; 44(5-6):259-265. PubMed ID: 28854435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midlife physical activity is associated with lower incidence of vascular dementia but not Alzheimer's disease.
    Hansson O; Svensson M; Gustavsson AM; Andersson E; Yang Y; Nägga K; Hållmarker U; James S; Deierborg T
    Alzheimers Res Ther; 2019 Oct; 11(1):87. PubMed ID: 31630687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High circulating levels of midregional proenkephalin A predict vascular dementia: a population-based prospective study.
    Holm H; Nägga K; Nilsson ED; Ricci F; Melander O; Hansson O; Bachus E; Fedorowski A; Magnusson M
    Sci Rep; 2020 May; 10(1):8027. PubMed ID: 32415209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
    Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
    PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors of vascular dementia in Thai stroke patients.
    Dharmasaroja PA; Limwongse C; Charernboon T
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104878. PubMed ID: 32417242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease.
    Nilsson ED; Melander O; Elmståhl S; Lethagen E; Minthon L; Pihlsgård M; Nägga K
    J Alzheimers Dis; 2016 Apr; 52(3):1047-53. PubMed ID: 27079711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traffic-Related Air Pollution and Dementia Incidence in Northern Sweden: A Longitudinal Study.
    Oudin A; Forsberg B; Adolfsson AN; Lind N; Modig L; Nordin M; Nordin S; Adolfsson R; Nilsson LG
    Environ Health Perspect; 2016 Mar; 124(3):306-12. PubMed ID: 26305859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of all-cause, Alzheimer's, and vascular dementia in adults with migraine in Korea: a population-based cohort study.
    Hurh K; Jeong SH; Kim SH; Jang SY; Park EC; Jang SI
    J Headache Pain; 2022 Aug; 23(1):108. PubMed ID: 36002812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of All-Cause Mortality in Diabetic Patients Taking β-Blockers.
    Tsujimoto T; Kajio H; Shapiro MF; Sugiyama T
    Mayo Clin Proc; 2018 Apr; 93(4):409-418. PubMed ID: 29545006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
    Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
    Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midlife Atherosclerosis and Development of Alzheimer or Vascular Dementia.
    Gustavsson AM; van Westen D; Stomrud E; Engström G; Nägga K; Hansson O
    Ann Neurol; 2020 Jan; 87(1):52-62. PubMed ID: 31721283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
    Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment (MCI).
    Forti P; Maioli F; Pisacane N; Rietti E; Montesi F; Ravaglia G
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():155-65. PubMed ID: 17317449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation.
    Patti G; Sticchi A; Pasceri V; Ricci F; Renda G; Hamrefors V; Melander O; Sutton R; Engström G; De Caterina R; Fedorowski A
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3145. PubMed ID: 30790434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
    Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
    JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive drugs and relevant cardiovascular pharmacotherapies and the risk of incident dementia in patients with atrial fibrillation.
    Wändell P; Carlsson AC; Sundquist J; Sundquist K
    Int J Cardiol; 2018 Dec; 272():149-154. PubMed ID: 30072151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
    Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality risk after dementia diagnosis by dementia type and underlying factors: a cohort of 15,209 patients based on the Swedish Dementia Registry.
    Garcia-Ptacek S; Farahmand B; Kåreholt I; Religa D; Cuadrado ML; Eriksdotter M
    J Alzheimers Dis; 2014; 41(2):467-77. PubMed ID: 24625796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.